Our Respiratory Trials

New GSK Asthma Study- Evaluating an experimental inhaler propellant

A Phase 3 study investigating the efficacy and long-term safety of the experimental, modified inhaler with a climate friendly propellant HFA-152a in comparison to the currently approved inhaler with propellant HFA-134a in participants aged 18 years and over with diagnosed asthma.

This study is only being conducted at our Central Coast site

Apply Now
Placeholder Image
Apply for future trials.
Paratus Clinical is always in need of dedicated patients who would like to contribute to answering important research questions.
If you would like to be contacted about future research opportunities, please select 'Register Now' and submit your details.
You will be contacted by a recruitment specialist shortly.